Market research
8EG.F Euglena Co., Ltd
F EUR Consumer Defensive
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 259M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.6%
- Beta
- -0.05
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- ISIN
- JP3944370000
- Market cap
- 259M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.6%
- Beta
- -0.05
About
About Euglena Co., Ltd
Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and social businesses; and invests in biotechnology related businesses. Further, the company provides genome analysis services. Euglena Co., Ltd. was incorporated in 2005 and is headquartered in Tokyo, Japan.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 8EG.F discussion.
5 years, 5 months ago
Euglena Co., Ltd is currently in a long term uptrend where the price is trading 15.7% above its 200 day moving average.
From a valuation standpoint, the stock is 93.7% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 7.1.
Euglena Co., Ltd's total revenue rose by 21.5% to $4B since the same quarter in the previous year.
Its net income has dropped by 42.7% to $-360M since the same quarter in the previous year.
Based on the above factors, Euglena Co., Ltd gets an overall score of 3/5.